ROIV Roivant Sciences Ltd. | BMG762791017
Financials
Trends
Details
| Breakdown | 31.03.2028 | 31.03.2027 | Change % |
|---|---|---|---|
| Total Revenue | 465.839.190 | 49.281.700 | 845.26% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -1,56 | -1,50 | 4.25% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 3 | 3 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |